Experimental compound slows blood cancer growth
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.
List view / Grid view
Researchers have identified a protein that plays a role in promoting blood cancer and have successfully used a novel compound to inhibit it, reducing tumour growth.
A new study has shown that proteins derived from the oncogene, KRAS, can transfer between colon cancer cells.
In figures released by the Home Office, the use of animal models has decreased down to 3.52 million procedures in 2018.
Researchers have developed a chip which facilitates and accelerates active substance production, characterisation and biological effectiveness.
A protein has been discovered as key for effective chemotherapy, meaning improved treatments for chemotherapy resistance can be developed.
Researchers have used machine learning to discover that the two most widespread DNA structures cause genome mutations that lead to cancer.
Using a novel technique, researchers have created new molecules effective at killing bacteria, providing new antibiotic drug targets.
Charlotte Walker-Osborn, a Partner and Head of Technology Sector (International) at global law-firm Eversheds Sutherland and a legal expert in technology law, explains some of the challenges and potential future of artificial intelligence (AI) in the field of drug discovery.
A new study found that betaine supplementations given to mice reduced schizophrenic behaviours, indicating a drug target.
A new report has stated that the majority of medical journals restrict their content for pharmaceutical industry professionals.
New research has identified an enzyme which causes degradation of dendritic spines, pointing to a drug target for Alzheimer’s.
A recent study has identified the DBC1 gene which leaves cancer cells more exposed to therapies.
A new medical imaging tracing method has been discovered by scientists which can better track drugs in the body.
A new study has shown that there are two populations of cells in the gut which leads to drug development potential.
Researchers have successfully created a multi-organ in vitro model to test toxicity and efficacy of drugs.